128 related articles for article (PubMed ID: 16650897)
1. Gammadelta T cells recognize tumor cells via CDR3delta region.
Xu C; Zhang H; Hu H; He H; Wang Z; Xu Y; Chen H; Cao W; Zhang S; Cui L; Ba D; He W
Mol Immunol; 2007 Jan; 44(4):302-10. PubMed ID: 16650897
[TBL] [Abstract][Full Text] [Related]
2. The recognition of gammadelta TCR to protein antigen does not depend on the hydrophobic I97 residue of CDR3delta.
Xi X; Cui L; He W
Int Immunol; 2010 Apr; 22(4):299-306. PubMed ID: 20181655
[TBL] [Abstract][Full Text] [Related]
3. Targeting solid tumors via T cell receptor complementarity-determining region 3delta in an engineered antibody.
Wang Z; Zhang T; Hu H; Zhang H; Yang Z; Cui L; He W
Cancer Lett; 2008 Dec; 272(2):242-52. PubMed ID: 18782650
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
6. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
Guo BL; Liu Z; Aldrich WA; Lopez RD
Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of gammadelta T cells in tumor immunology.
Kabelitz D; Wesch D; He W
Cancer Res; 2007 Jan; 67(1):5-8. PubMed ID: 17210676
[TBL] [Abstract][Full Text] [Related]
8. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
[TBL] [Abstract][Full Text] [Related]
9. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
10. Vdelta1 T cell receptor binds specifically to MHC I chain related A: molecular and biochemical evidences.
Zhao J; Huang J; Chen H; Cui L; He W
Biochem Biophys Res Commun; 2006 Jan; 339(1):232-40. PubMed ID: 16297874
[TBL] [Abstract][Full Text] [Related]
11. Identification of human T cell receptor gammadelta-recognized epitopes/proteins via CDR3delta peptide-based immunobiochemical strategy.
Chen H; He X; Wang Z; Wu D; Zhang H; Xu C; He H; Cui L; Ba D; He W
J Biol Chem; 2008 May; 283(18):12528-37. PubMed ID: 18321859
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
[TBL] [Abstract][Full Text] [Related]
13. Profiling the pattern of the human T-cell receptor γδ complementary determinant region 3 repertoire in patients with lung carcinoma via high-throughput sequencing analysis.
Chen H; Zou M; Teng D; Hu Y; Zhang J; He W
Cell Mol Immunol; 2019 Mar; 16(3):250-259. PubMed ID: 30886423
[TBL] [Abstract][Full Text] [Related]
14. CDR3δ -grafted γ9δ2T cells mediate effective antitumor reactivity.
Zhao H; Xi X; Cui L; He W
Cell Mol Immunol; 2012 Mar; 9(2):147-54. PubMed ID: 21909128
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulation in the tissues by gammadelta T cells.
Hayday A; Tigelaar R
Nat Rev Immunol; 2003 Mar; 3(3):233-42. PubMed ID: 12658271
[TBL] [Abstract][Full Text] [Related]
16. Antigen recognition determinants of gammadelta T cell receptors.
Shin S; El-Diwany R; Schaffert S; Adams EJ; Garcia KC; Pereira P; Chien YH
Science; 2005 Apr; 308(5719):252-5. PubMed ID: 15821090
[TBL] [Abstract][Full Text] [Related]
17. In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma.
Burjanadzé M; Condomines M; Reme T; Quittet P; Latry P; Lugagne C; Romagne F; Morel Y; Rossi JF; Klein B; Lu ZY
Br J Haematol; 2007 Oct; 139(2):206-16. PubMed ID: 17897296
[TBL] [Abstract][Full Text] [Related]
18. Antigen specificity of gammadelta T cells depends primarily on the flanking sequences of CDR3delta.
Xi X; Guo Y; Chen H; Xu C; Zhang H; Hu H; Cui L; Ba D; He W
J Biol Chem; 2009 Oct; 284(40):27449-55. PubMed ID: 19666468
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
[TBL] [Abstract][Full Text] [Related]
20. Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumors.
Oberg HH; Janitschke L; Sulaj V; Weimer J; Gonnermann D; Hedemann N; Arnold N; Kabelitz D; Peipp M; Bauerschlag D; Wesch D
J Leukoc Biol; 2020 Jun; 107(6):1081-1095. PubMed ID: 31833593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]